A client has been newly prescribed with cyclobenzaprine (Flexeril). Which of the following statements indicates the correct therapeutic use for this medication?

Choice A rationale

Combining multiple hepatotoxic medications increases the risk of liver damage due to cumulative toxicity effects.

Choice B rationale

Liver damage impairs the liver's ability to metabolize medications, leading to medication accumulation and potential adverse effects.

Choice C rationale

Combining hepatotoxic medications does not decrease the risk of liver damage; it increases it, as multiple toxic agents compound the stress on the liver.

Choice D rationale

Common manifestations of hepatotoxicity include symptoms like nausea, vomiting, jaundice, dark urine, abdominal discomfort, and anorexia, indicating liver dysfunction.

Choice A rationale: Administering a small test dose is not typically required before giving an antibiotic unless there is a known history of severe allergies. It is more important to identify the causative organism to ensure the appropriate antibiotic is used.

Choice B rationale: Having epinephrine available is a safety measure for potential severe allergic reactions, but it is not the most immediate priority. Ensuring the antibiotic is appropriate for the infection is crucial.

Choice C rationale: Monitoring the client's temperature and blood pressure is important, but it is not the most immediate priority before administering the antibiotic. These parameters should be monitored throughout treatment.

Choice D rationale: Obtaining a urine specimen for culture and sensitivity is the most important action before administering the antibiotic. This ensures that the correct antibiotic is prescribed based on the specific bacteria causing the infection. It helps prevent the use of ineffective antibiotics and reduces the risk of antibiotic resistance.